Small cell lung cancer (SCLC) is typically characterized by a poorly inflamed tumor microenvironment. The prognostic significance of tumor-based immune infiltration and blood-based immune parameters in SCLC remains insufficiently established.
Silva et al. (Tue,) studied this question.